Our group and others have demonstrated that defective activation of the antiviral PKR-eIF2α pathway is a key determinant of direct oncolysis initiated by reovirus infection (10, 17, 44, 45), enabling efficient viral replication, and immune activation in a later stage (22). This evidence concerns the gene EIF2A and Reoviridae infectious disease.